Citigroup’s Verastem VSTM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$65K Sell
12,261
-352,175
-97% -$2.17M ﹤0.01% 4431
2025
Q4
$2.81M Buy
364,436
+362,421
+17,986% +$3.23M ﹤0.01% 2432
2025
Q3
$17.8K Sell
2,015
-31,351
-94% -$233K ﹤0.01% 4859
2025
Q2
$138K Buy
33,366
+5,761
+21% +$36.1K ﹤0.01% 4255
2025
Q1
$166K Sell
27,605
-3,446
-11% -$21.1K ﹤0.01% 4302
2024
Q4
$161K Buy
31,051
+3,067
+11% +$12.1K ﹤0.01% 4551
2024
Q3
$83.7K Buy
27,984
+22,456
+406% +$60.9K ﹤0.01% 4852
2024
Q2
$16.5K Sell
5,528
-71,692
-93% -$591K ﹤0.01% 5048
2024
Q1
$911K Buy
77,220
+3,312
+4% +$38.3K ﹤0.01% 3106
2023
Q4
$602K Buy
73,908
+43,833
+146% +$315K ﹤0.01% 3264
2023
Q3
$245K Buy
+30,075
New +$289K ﹤0.01% 3560
2022
Q4
Sell
-3,596
Closed -$37K 5973
2022
Q3
$37K Buy
3,596
+2,785
+343% +$38.8K ﹤0.01% 4517
2022
Q2
$12K Sell
811
-37
-4% -$589 ﹤0.01% 5293
2022
Q1
$14K Sell
848
-38,027
-98% -$655K ﹤0.01% 5368
2021
Q4
$956K Buy
38,875
+14,180
+57% +$448K ﹤0.01% 3309
2021
Q3
$913K Sell
24,695
-6,813
-22% -$250K ﹤0.01% 3154
2021
Q2
$1.54M Buy
31,508
+30,297
+2,502% +$1.26M ﹤0.01% 2889
2021
Q1
$36K Sell
1,211
-1,953
-62% -$54.7K ﹤0.01% 4899
2020
Q4
$81K Buy
3,164
+2,382
+305% +$47.9K ﹤0.01% 5709
2020
Q3
$11K Sell
782
-3,045
-80% -$50.4K ﹤0.01% 6577
2020
Q2
$79K Buy
3,827
+3,071
+406% +$81.2K ﹤0.01% 5768
2020
Q1
$24K Sell
756
-7
-0.9% -$176 ﹤0.01% 6582
2019
Q4
$12K Sell
763
-11,279
-94% -$162K ﹤0.01% 7153
2019
Q3
$175K Sell
12,042
-217
-2% -$3.52K ﹤0.01% 5252
2019
Q2
$222K Buy
12,259
+11,923
+3,549% +$270K ﹤0.01% 5169
2019
Q1
$12K Sell
336
-75,406
-100% -$2.98M ﹤0.01% 7188
2018
Q4
$3.05M Buy
75,742
+53,879
+246% +$3.29M ﹤0.01% 2284
2018
Q3
$1.9M Buy
21,863
+21,260
+3,526% +$2.11M ﹤0.01% 2786
2018
Q2
$50K Buy
+603
New +$36.9K ﹤0.01% 6287
2016
Q2
Sell
-2,255
Closed -$42K 7472
2016
Q1
$42K Buy
2,255
+1,356
+151% +$21.8K ﹤0.01% 6195
2015
Q4
$20K Buy
899
+414
+85% +$9.81K ﹤0.01% 6488
2015
Q3
$10K Buy
485
+92
+23% +$7.28K ﹤0.01% 6438
2015
Q2
$35K Sell
393
-112
-22% -$11.8K ﹤0.01% 5763
2015
Q1
$62K Sell
505
-273
-35% -$28.6K ﹤0.01% 5397
2014
Q4
$85K Buy
778
+663
+577% +$71.7K ﹤0.01% 5360
2014
Q3
$12K Buy
115
+99
+619% +$10.4K ﹤0.01% 6181
2014
Q2
$2K Sell
16
-366
-96% -$39.8K ﹤0.01% 6782
2014
Q1
$50K Sell
382
-229
-37% -$36.6K ﹤0.01% 5488
2013
Q4
$83K Buy
611
+593
+3,294% +$77.9K ﹤0.01% 5389
2013
Q3
$2K Buy
18
+16
+800% +$2.79K ﹤0.01% 6604
2013
Q2
$0 Buy
+2
New +$241 ﹤0.01% 6800

Other funds holding VSTM

Citigroup's VSTM Position: Q1 2026 in Review

Citigroup reduced its Verastem (VSTM) stake by 97% in Q1 2026, selling an estimated $2.17M and leaving 12,261 shares worth $65K. The position accounts for ﹤0.01% of the portfolio, ranked #4431.

Citigroup first reported a position in VSTM in Q2 2013 and has held it in 41 quarters since. The position peaked at $3.05M in Q4 2018. 155 funds tracked by Wall St. Rank hold VSTM as of Q1 2026.

  • Citigroup held 12,261 shares of Verastem worth $65K as of Q1 2026.
  • Citigroup sold 352,175 Verastem shares in Q1 2026, an estimated $2.17M.
  • Verastem made up ﹤0.01% of Citigroup's portfolio in Q1 2026, its #4431 holding.
  • Citigroup first reported a position in Verastem in Q2 2013 and has held it in 41 quarters since.
  • Citigroup's Verastem position peaked at $3.05M in Q4 2018.
  • 155 funds tracked by Wall St. Rank held Verastem as of Q1 2026.

Based on Citigroup's 13F filing for Q1 2026, filed 11 May 2026.